This video provides a progress update on cutting-edge research exploring epigenetic reprogramming and small molecule cocktails for cellular rejuvenation.

Dr David Sinclair delve into the latest studies on how these approaches can potentially reverse the effects of aging at the cellular level. Topics covered include:

• The mechanisms of epigenetic reprogramming using Yamanaka factors. The development and testing of novel small molecule cocktails. Applications in various tissues and organs Research on reversing cellular senescence and restoring cell identity. The use of AI for high-throughput screening of potential rejuvenating compounds.
This update highlights recent advancements, challenges, and future directions in this exciting field of research.

* Credits to ARRD \& Dr David Sinclair*

It does not say how much he was taking. It was my understanding people can take under 10 mg per week and get no side effects.

In an ironic twist of fate, biohacker Bryan Johnson discovers that the drug he used to freeze time was possibly fast-forwarding it.

Not a dramatic increase, but a good one.

Loyal, a US biotech startup, has been conducting research and development on LOY-002, a potential drug for extending the lifespan of dogs.

The Guardian reported that the company expects to launch this beef-flavored pill on the market early next year.